Of note, AD-related pathologies prompt the activation of microglia and the release of pro-inflammatory/inflammatory cytokines, which inhibit insulin receptor substrate 1 (IRS-1) (Zheng and Wang 2021). Here, IRS1 is linked to Alzheimer disease.